	Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patients. Front Immunol Poddubskaya E, Suntsova M, Lyadova M, Luppov D, Guryanova A, Lyadov V, Garazha A, Sorokin M, Semenova A, Shatalov V, Biakhova M, Simonov A, Moisseev A, Buzdin A. PMID: 39723204 [PubMed - indexed for MEDLINE]
	Orthoallosteric EGFR-TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation. Drug Dev Res Ahmad I, Patel HM. PMID: 39722446 [PubMed - indexed for MEDLINE]
	EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in Patients with Pulmonary Ground-Glass Opacities. Ann Surg Oncol Tang WF, Qiu ZB, Chu XP, Zeng YM, Hu YB, Tang X, Yu YF, Li WH, Zhong WZ, Huang WZ, Liang Y. PMID: 39722087 [PubMed - as supplied by publisher]
	Liver Function Biomarkers and Lung Cancer Risk: A Prospective Cohort Study in the UK Biobank. Clin Respir J Sun X, Guo Z, Zhang Y, Liu Z, Xiong J, Cai M, Tan J, Lin Y, Yu Z, Du K, Lu E, Xia X. PMID: 39721983 [PubMed - indexed for MEDLINE]
	Early Experience of Uniportal Robotic-Assisted Anatomic Resection in Lung Cancer Patients: Is it Safe and Feasible for Direct Transition From Uniportal Video Thoracoscopic-Assisted Surgery to Uniportal Robotic-Assisted Surgery? Asian J Endosc Surg Kuo YC, Wu CY, Hsieh MJ, Gonzalez-Rivas D, Yang TY, Wu CF. PMID: 39721797 [PubMed - indexed for MEDLINE]
	Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings. J Immunother Cancer Henick BS, Koch PD, Gainor JF, Awad MM, Chiuzan C, Izard S, Georgis Y, Mallick S, Garofano RF, Wong CV, Saqi A, Grindheim J, Schulze K, Sonett JR, Rizvi NA, Izar B, Taylor AM, Shu CA. PMID: 39721753 [PubMed - indexed for MEDLINE]
	High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC. J Immunother Cancer Altan M, Li R, Li Z, Chen R, Sheshadri A, Tran HT, Little L, Baguley J, Sinson J, Vokes N, Gandhi S, Antonoff MB, Swisher SG, Lizee G, Reuben A, Heymach JV, Zhang J. PMID: 39721752 [PubMed - indexed for MEDLINE]
	Identifying the population to be targeted in a lung cancer screening programme in Denmark. BMJ Open Respir Res Fernández Montejo MDP, Saghir Z, Bødtger U, Jepsen R, Lynge E, Lophaven S. PMID: 39721745 [PubMed - indexed for MEDLINE]
	Clinical characteristics and survival outcomes in patients with pulmonary sarcomatoid carcinoma: a multicenter retrospective study. Clin Transl Oncol Du Z, Qin Y, Lv Y, Gao J, Chen S, Du X, Li T, Hu Y, Liu Z. PMID: 39720986 [PubMed - as supplied by publisher]
	The Spatial Distribution of Brain Metastasis Is Determined by the Heterogeneity of the Brain Microenvironment. Hum Brain Mapp Liang X, Bao H, Ren P, Lai J, Bai Y, Liu Y, Lv Z, Hu J, Yan Z, Wang Z, Pu T, Wang R, Hou Z, Liang P, Wang Y. PMID: 39720836 [PubMed - indexed for MEDLINE]
	Decoding the prognostic landscape of LUAD: the interplay between N(6)-methyladenosine modification and immune microenvironment. Front Immunol Chen Q, Wan W, Zhao Q, Li J, Xiong Y, Yuan Y, Tang L, Wu X, Xing W, Guo W, Lu D, Ao L, Xu X, Ao X. PMID: 39720723 [PubMed - indexed for MEDLINE]
	In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma. Front Immunol Wang X, Jiang L, Zhao J, Wu M, Xiong J, Wu X, Weng X. PMID: 39720721 [PubMed - indexed for MEDLINE]
	Efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB non-small cell lung cancer (periSCOPE): an open-label, single-arm, phase II trial. EClinicalMedicine Yu X, Huang C, Du L, Wang C, Yang Y, Yu X, Lin S, Yang C, Zhao H, Cai S, Wang Z, Wang L, Guo X, Zhang B, Yu Z, He J, Ma K. PMID: 39720604 [PubMed]
	Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies. Front Oncol Zhang L, Zhang F, Li G, Xiang X, Liang H, Zhang Y. PMID: 39720561 [PubMed]
	Recent advances in the treatment of non-small cell lung cancer with MET inhibitors. Front Chem Zhang D, Zhang W, Liu H, Liu P, Li C, Liu Y, Han J, Zhu G. PMID: 39720556 [PubMed]
	The cerebral metabolic mechanism of group computer magnanimous therapy based on magnetic resonance spectroscopy: effects on improving magnanimous-enterprising levels of lung cancer patients. Front Psychiatry Liu Q, Ma Q, Sun Q, Huang X. PMID: 39720429 [PubMed]
	Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications. Noncoding RNA Res Hashemi M, Fard AA, Pakshad B, Asheghabadi PS, Hosseinkhani A, Hosseini AS, Moradi P, Mohammadbeygi Niye M, Najafi G, Farahzadi M, Khoushab S, Taheriazam A, Farahani N, Mohammadi M, Daneshi S, Nabavi N, Entezari M. PMID: 39720352 [PubMed]
	Primary pleural schwannoma: a rare case report. J Med Life Amir M, Sheikh S. PMID: 39720172 [PubMed - indexed for MEDLINE]
	Clinical significance of the combined systemic immune-inflammatory index and prognostic nutritional index in predicting the prognosis of patients with extensive-stage small-cell lung cancer receiving immune-combination chemotherapy. BMC Cancer Wang B, Zhang J, Shi Y, Wang Y. PMID: 39719567 [PubMed - indexed for MEDLINE]
	Pulmonologists-level lung cancer detection based on standard blood test results and smoking status using an explainable machine learning approach. Sci Rep Flyckt RNH, Sjodsholm L, Henriksen MHB, Brasen CL, Ebrahimi A, Hilberg O, Hansen TF, Wiil UK, Jensen LH, Peimankar A. PMID: 39719477 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 144294

Page 1 of 7215



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy